SCHEMBL19377260

SCHEMBL19377260

CCc1ccc(Cl)c(C(=O)NC(=O)Nc2ccc(S(=O)(=O)Cc3ccc(CO)cc3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCTP Q9UKL6 7/20 0.46
▸ GHSR Q92847 1/20 0.45
▸ RORC P51449 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ STARD10 Q9Y365 3/20 0.43
▸ STARD7 Q9NQZ5 1/20 0.43
▸ POLB P06746 2/20 0.41
▸ PYGL P06737 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ USP28 Q96RU2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377005 0.88 GHSR (0.53) PCTPGHSRSTARD10STARD7
SCHEMBL19377387 0.84 GHSR (0.45) PCTPGHSRRORCMEN1KMT2A
SCHEMBL19406945 0.78 GHSR (0.53) PCTPGHSRSTARD10STARD7ALDH1A1
SCHEMBL11232803 0.77 PCTP (0.59) PCTPKMT2ASTARD10POLBPYGL
SCHEMBL19377401 0.76 GHSR (0.70) PCTPGHSR
SCHEMBL24800034 0.75 GHSR (0.50) GHSRMEN1KMT2APOLBTLR9
SCHEMBL19377110 0.74 DRD2 (0.54) PCTPGHSRMEN1KMT2ASTARD10
SCHEMBL19377430 0.73 GHSR (0.46) PCTPGHSRMEN1KMT2ASTARD10
SCHEMBL19377302 0.72 HTR6 (0.57) PCTPGHSRMEN1KMT2ASTARD10
SCHEMBL19377456 0.69 NAMPT (0.40) PCTPGHSRRORCSTARD10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR PCTP 2942/4885GHSR 2/4885RORC 2317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback